Fresenius Medical Care AG
FMS24.985USD
-0.085-0.34%
Cierre 04/29, 16:00（ET）Cotizaciones retrasadas 15 min
7.33BCap. mercado
10.26P/E TTM
Más Datos de Fresenius Medical Care AG Compañía
Fresenius Medical Care AG, formerly Fresenius Medical Care AG & Co. KGaA is a Germany-based kidney dialysis institute. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD) and offers other extracorporeal therapies, as well as other healthcare services. It has two operating segments such as care delivery segment which consolidates the global health care services business and care enablement segment includes research and development (R&D), manufacturing, supply chain, and commercial operations. It develops and manufactures health care products, which includes dialysis and non-dialysis products. Such as hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals, and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. It owns, operates, or manages dialysis clinics sells products to other dialysis providers.
Información de la empresa
Código de la empresaFMS
Nombre de la empresaFresenius Medical Care AG
Fecha de salida a bolsaOct 02, 1996
Fundada en2006
Director ejecutivoDr. Katarzyna Mazur-Hofsaess
Número de empleados- -
Tipo de seguridadOrdinary Share
Fin del año fiscalOct 02
DirecciónElse-Kroener-Strasse 1
CiudadBAD HOMBURG VOR DER HOHE
Bolsa de valoresTSX Venture Exchange (former Canadian Ventures Exchange)
PaísGermany
Código postal61352
Teléfono4961726090
Sitio Webhttps://www.freseniusmedicalcare.com/
Código de la empresaFMS
Fecha de salida a bolsaOct 02, 1996
Fundada en2006
Ejecutivos de la empresa
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Craig Cordola, Ed.D.
Mr. Craig Cordola, Ed.D.
Member of the Management Board, Chief Executive Officer - Care Delivery
Member of the Management Board, Chief Executive Officer - Care Delivery
--
--
Dr. Joerg Haering
Dr. Joerg Haering
Member of the Management Board - Legal, Compliance, Human Resources and Labor Relations Director
Member of the Management Board - Legal, Compliance, Human Resources and Labor Relations Director
--
--
Ms. Beate Hassdenteufel
Ms. Beate Hassdenteufel
Member of the Supervisory Board, Employee Representatives
Member of the Supervisory Board, Employee Representatives
--
--
Dr. Katarzyna Mazur-Hofsaess
Dr. Katarzyna Mazur-Hofsaess
Member of the Management Board, Chief Executive Officer - Care Enablement
Member of the Management Board, Chief Executive Officer - Care Enablement
--
--
Dr. Dominik Heger
Dr. Dominik Heger
Head of Investor Relations, Strategic Development and Communications, EVP
Head of Investor Relations, Strategic Development and Communications, EVP
--
--
Dr. Marcus Kuhnert
Dr. Marcus Kuhnert
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--
Ms. Stefanie Balling
Ms. Stefanie Balling
Vice Chairman of the Supervisory Board
Vice Chairman of the Supervisory Board
--
--
Mr. Shervin J. Korangy
Mr. Shervin J. Korangy
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--
Mr. Ralf Erkens
Mr. Ralf Erkens
Member of the Supervisory Board, Employee Representatives
Member of the Supervisory Board, Employee Representatives
--
--
Dr. Frank W. Maddux, M.D.
Dr. Frank W. Maddux, M.D.
Member of the Management Board, Global Chief Medical Officer
Member of the Management Board, Global Chief Medical Officer
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Craig Cordola, Ed.D.
Mr. Craig Cordola, Ed.D.
Member of the Management Board, Chief Executive Officer - Care Delivery
Member of the Management Board, Chief Executive Officer - Care Delivery
--
--
Dr. Joerg Haering
Dr. Joerg Haering
Member of the Management Board - Legal, Compliance, Human Resources and Labor Relations Director
Member of the Management Board - Legal, Compliance, Human Resources and Labor Relations Director
--
--
Ms. Beate Hassdenteufel
Ms. Beate Hassdenteufel
Member of the Supervisory Board, Employee Representatives
Member of the Supervisory Board, Employee Representatives
--
--
Dr. Katarzyna Mazur-Hofsaess
Dr. Katarzyna Mazur-Hofsaess
Member of the Management Board, Chief Executive Officer - Care Enablement
Member of the Management Board, Chief Executive Officer - Care Enablement
--
--
Dr. Dominik Heger
Dr. Dominik Heger
Head of Investor Relations, Strategic Development and Communications, EVP
Head of Investor Relations, Strategic Development and Communications, EVP
--
--
Dr. Marcus Kuhnert
Dr. Marcus Kuhnert
Independent Member of the Supervisory Board
Independent Member of the Supervisory Board
--
--
Desglose de ingresos
Divisa: USDHora de actualización: jue., 20 de feb
Divisa: USDHora de actualización: jue., 20 de feb
FY2022
FY2021
FY2020
FY2019
FY2018
Sin datos
Por regiónUSD
Nombre
Ganancia
Proporción
North America
14.27B
69.95%
Rest of the world
5.62B
27.54%
Germany
512.41M
2.51%
Por negocio
Por región
Sin datos
Accionista
Hora de actualización: vie., 21 de feb
Hora de actualización: vie., 21 de feb
Estadísticas de accionistas
Tipo
Estadísticas de accionistas
Accionista
Proporción
Pzena Investment Management, LLC
2.60%
Wellington Management Company, LLP
1.40%
Fiduciary Management, Inc.
1.07%
Dodge & Cox
0.71%
Aristotle Capital Management, LLC
0.20%
Other
94.01%
Estadísticas de accionistas
Accionista
Proporción
Pzena Investment Management, LLC
2.60%
Wellington Management Company, LLP
1.40%
Fiduciary Management, Inc.
1.07%
Dodge & Cox
0.71%
Aristotle Capital Management, LLC
0.20%
Other
94.01%
Tipo
Accionista
Proporción
Investment Advisor/Hedge Fund
5.01%
Investment Advisor
2.07%
Hedge Fund
0.32%
Research Firm
0.07%
Family Office
0.01%
Other
92.52%
Participación institucional
Hora de actualización: lun., 20 de ene
Hora de actualización: lun., 20 de ene
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q1
321
44.02M
7.50%
-2.98M
2024Q4
337
43.96M
7.49%
-3.12M
2024Q3
324
43.49M
7.41%
-1.75M
2024Q2
342
41.23M
7.03%
-8.59M
2024Q1
361
42.90M
7.31%
-5.86M
2023Q4
361
42.80M
7.29%
-6.45M
2023Q3
365
42.72M
7.28%
-7.66M
2023Q2
367
43.73M
7.45%
-13.55M
2023Q1
371
50.41M
8.59%
-15.36M
2022Q4
381
58.35M
9.94%
+10.96M
Ver más
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
Pzena Investment Management, LLC
15.28M
2.6%
-932.64K
-5.75%
Dec 31, 2024
Wellington Management Company, LLP
8.20M
1.4%
--
--
Dec 31, 2024
Fiduciary Management, Inc.
6.31M
1.07%
-252.52K
-3.85%
Dec 31, 2024
Dodge & Cox
4.17M
0.71%
--
--
Dec 31, 2024
Aristotle Capital Management, LLC
1.16M
0.2%
--
--
Dec 31, 2024
Parametric Portfolio Associates LLC
973.20K
0.17%
+51.68K
+5.61%
Dec 31, 2024
Millennium Management LLC
722.24K
0.12%
+708.86K
+5.30K%
Dec 31, 2024
Integral Health Asset Management, LLC
600.00K
0.1%
+150.00K
+33.33%
Dec 31, 2024
Goldman Sachs Asset Management, L.P.
530.60K
0.09%
+76.80K
+16.92%
Dec 31, 2024
Janus Henderson Investors
528.22K
0.09%
+114.50K
+27.67%
Dec 31, 2024
Ver más
ETFs relacionados
Hora de actualización: dom., 6 de abr
Hora de actualización: dom., 6 de abr
Nombre
Proporción
The Opal International Dividend Income ETF
1.67%
Cultivar ETF
1.49%
ActivePassive International Equity ETF
0.16%
Avantis Responsible International Equity ETF
0.04%
Avantis International Equity ETF
0.01%
Unusual Whales Subversive Republican Trading ETF
0%
Pacer Developed Markets International Cash Cws 100
0%
Inspire Fidelis Multi Factor ETF
0%
Unusual Whales Subversive Democratic Trading ETF
0%
DFA Dimensional International Core Equity 2 ETF
0%
Ver más
The Opal International Dividend Income ETF
Proporción1.67%
Cultivar ETF
Proporción1.49%
ActivePassive International Equity ETF
Proporción0.16%
Avantis Responsible International Equity ETF
Proporción0.04%
Avantis International Equity ETF
Proporción0.01%
Unusual Whales Subversive Republican Trading ETF
Proporción0%
Pacer Developed Markets International Cash Cws 100
Proporción0%
Inspire Fidelis Multi Factor ETF
Proporción0%
Unusual Whales Subversive Democratic Trading ETF
Proporción0%
DFA Dimensional International Core Equity 2 ETF
Proporción0%
Dividendos
Un total de
1.94B
USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Apr 15, 2024
FMS.NB Final Cash Dividend of gross USD 0.642838 paid on Jun 03, 2024 going ex on May 17, 2024
May 20, 2024
Jun 03, 2024
May 17, 2024
May 03, 2023
FMS.NB Final Cash Dividend of gross USD 0.604856 paid on Jun 01, 2023 going ex on May 17, 2023
May 18, 2023
Jun 01, 2023
May 17, 2023
Apr 28, 2022
FMS.NB Final Cash Dividend of gross USD 0.708547 paid on May 27, 2022 going ex on May 13, 2022
May 16, 2022
May 27, 2022
May 13, 2022
May 16, 2021
FMS.NB Final Cash Dividend of gross USD 0.819276 paid on Jun 07, 2021 going ex on May 24, 2021
May 25, 2021
Jun 07, 2021
May 24, 2021
Aug 12, 2020
FMS.NB Final Cash Dividend of gross USD 0.71688 paid on Sep 11, 2020 going ex on Aug 28, 2020
Aug 31, 2020
Sep 11, 2020
Aug 28, 2020
División de acciones
Fecha
Tipo
Relación
Sin datos
Fecha
Tipo
Relación
Sin datos